Huge advantage with ANGPTL3 inhibitor for HoFH patients with minimal to zero LDLR activity

Media formats available:

A novel small binding protein that targets PCSK9
A novel small binding protein that targets PCSK9
EAS 2020
A novel small binding protein that targets PCSK9
- Prof. Evan Stein
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
EAS 2020
Small interfering RNA against PCSK9 reduces LDL-c in HeFH independent of genotype
- Prof. Frederick Raal

PACE-CME